- Home
- PEPG vs CGO Comparison
PEPG vs CGO Comparison
Compare PEPG & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- CGO
- Stock Information
- Founded
- PEPG 2018
- CGO 2004
- Country
- PEPG United States
- CGO United States
- Employees
- PEPG 76
- CGO N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- CGO Investment Managers
- Sector
- PEPG Health Care
- CGO Finance
- Exchange
- PEPG Nasdaq
- CGO Nasdaq
- Market Cap
- PEPG 118.3M
- CGO 114.2M
- IPO Year
- PEPG 2022
- CGO N/A
- Fundamental
- Price
- PEPG $3.63
- CGO $11.66
- Analyst Decision
- PEPG Buy
- CGO
- Analyst Count
- PEPG 3
- CGO 0
- Target Price
- PEPG $14.67
- CGO N/A
- AVG Volume (30 Days)
- PEPG 297.7K
- CGO 34.7K
- Earning Date
- PEPG 11-07-2024
- CGO 01-01-0001
- Dividend Yield
- PEPG N/A
- CGO 9.25%
- EPS Growth
- PEPG N/A
- CGO N/A
- EPS
- PEPG N/A
- CGO N/A
- Revenue
- PEPG N/A
- CGO N/A
- Revenue This Year
- PEPG N/A
- CGO N/A
- Revenue Next Year
- PEPG N/A
- CGO N/A
- P/E Ratio
- PEPG N/A
- CGO N/A
- Revenue Growth
- PEPG N/A
- CGO N/A
- 52 Week Low
- PEPG $2.90
- CGO $7.90
- 52 Week High
- PEPG $19.30
- CGO $10.93
- Technical
- Relative Strength Index (RSI)
- PEPG 27.87
- CGO 40.91
- Support Level
- PEPG $4.00
- CGO $11.52
- Resistance Level
- PEPG $5.72
- CGO $11.84
- Average True Range (ATR)
- PEPG 0.68
- CGO 0.19
- MACD
- PEPG -0.09
- CGO -0.03
- Stochastic Oscillator
- PEPG 18.48
- CGO 22.13
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in global equities, convertible securities, and high-yield corporate bonds.